NYSE:RAD - Rite Aid Stock Price, News, & Analysis

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Rite Aid shares reverse split before market open on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

Rite Aid Co. (NYSE:RAD) released its earnings results on Thursday, April, 11th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.60) by $0.40. The company had revenue of $5.38 billion for the quarter, compared to analysts' expectations of $5.56 billion. Rite Aid had a negative net margin of 1.95% and a negative return on equity of 1.21%. During the same period last year, the business earned ($0.20) earnings per share. View Rite Aid's Earnings History.

Rite Aid is scheduled to release their next quarterly earnings announcement on Wednesday, June 26th 2019. View Earnings Estimates for Rite Aid.

Rite Aid updated its FY 2020 earnings guidance on Thursday, April, 11th. The company provided earnings per share guidance of $-0.01-0.04 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.02. The company issued revenue guidance of $21.5-21.9 billion, compared to the consensus revenue estimate of $22.09 billion.

6 equities research analysts have issued twelve-month target prices for Rite Aid's stock. Their forecasts range from $20.00 to $120.00. On average, they anticipate Rite Aid's share price to reach $44.00 in the next twelve months. This suggests a possible upside of 538.6% from the stock's current price. View Analyst Price Targets for Rite Aid.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 2 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Rite Aid.

News coverage about RAD stock has trended positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rite Aid earned a news impact score of 2.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the next few days. View News Stories for Rite Aid.

Rite Aid saw a increase in short interest in May. As of May 31st, there was short interest totalling 12,184,000 shares, an increase of 9.8% from the April 30th total of 11,096,500 shares. Based on an average trading volume of 1,640,000 shares, the days-to-cover ratio is currently 7.4 days. Approximately 1.2% of the shares of the company are sold short. View Rite Aid's Current Options Chain.

Some companies that are related to Rite Aid include 111 (YI), Petmed Express (PETS), Diplomat Pharmacy (DPLO), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (cenx), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Mr. Cooper Group (COOP), Cleveland-Cliffs (clf), Advanced Micro Devices (AMD), General Electric (ge), Lantronix (LTRX) and AK Steel (aks).

Rite Aid's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include OppenheimerFunds Inc. (92.76%), JPMorgan Chase & Co. (46.77%), Private Management Group Inc. (7.19%), California Public Employees Retirement System (6.44%), Gabelli Funds LLC (3.52%) and Gamco Investors INC. ET AL (3.03%). View Institutional Ownership Trends for Rite Aid.

RAD stock was sold by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Alpine Global Management LLC, Creative Planning, Diversified Investment Strategies LLC, Gabelli Funds LLC, Private Management Group Inc., Salzhauer Michael and Gamco Investors INC. ET AL. View Insider Buying and Selling for Rite Aid.

RAD stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Connor Clark & Lunn Investment Management Ltd., Numen Capital LLP, Dupont Capital Management Corp, BNP Paribas Arbitrage SA, Cumberland Advisors Inc., MetLife Investment Advisors LLC and Boenning & Scattergood Inc.. View Insider Buying and Selling for Rite Aid.

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of RAD stock can currently be purchased for approximately $6.89.

Rite Aid has a market capitalization of $370.88 million and generates $21.64 billion in revenue each year. Rite Aid employs 51,000 workers across the globe.View Additional Information About Rite Aid.

The official website for Rite Aid is http://www.riteaid.com/.

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17011. The company can be reached via phone at 717-761-2633 or via email at [email protected]